Other proteins like the myocyte-specific enhancer transcription factor 2D (MEF2D), that is, a bona fide CMA substrate [40], have been observed to increase their cytosolic levels in mice models of PD, in PD patients [41] and in neurons with partial blockage of CMA [40]. Here, MEF2D is linked to Parkinson disease.